Variants and new entities of bladder cancer
Antonio López-Beltrán(University of Córdoba), Liang Cheng(Brown University), Maria Rosaria Raspollini(Azienda Ospedaliero-Universitaria Careggi), Vanessa Henriques(Champalimaud Foundation), Rodolfo Montironi(Marche Polytechnic University), Alessia Cimadamore(University of Udine)
Cited by 173
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289